Profile | GDS4284 / 204081_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 669.181 | 68 |
GSM687648 | Patient 402 control | 1245.58 | 77 |
GSM687653 | Patient 403 control | 344.276 | 59 |
GSM687658 | Patient 404 control | 1629.12 | 81 |
GSM687663 | Patient 411 control | 1309.52 | 78 |
GSM687668 | Patient 422 control | 499.597 | 64 |
GSM687673 | Patient 424 control | 713.292 | 69 |
GSM687678 | Patient 425 control | 958.438 | 73 |
GSM687683 | Patient 427 control | 1049.82 | 74 |
GSM687688 | Patient 428 control | 213.868 | 50 |
GSM687695 | Patient 441 control | 10558.7 | 97 |
GSM687699 | Patient 443 control | 1794.39 | 83 |
GSM687704 | Patient 444 control | 1039.59 | 75 |
GSM687707 | Patient 448 control | 741.002 | 70 |
GSM687712 | Patient 449 control | 397.704 | 60 |
GSM687719 | Patient 450 control | 1375.01 | 79 |
GSM687724 | Patient 451 control | 1387.57 | 79 |
GSM687728 | Patient 452 control | 1580.41 | 81 |
GSM687646 | Patient 401 treated 24h | 365.491 | 58 |
GSM687649 | Patient 402 treated 24h | 973.188 | 73 |
GSM687665 | Patient 411 treated 24h | 1609.99 | 81 |
GSM687651 | Patient 402 treated 4 weeks | 1250.47 | 77 |
GSM687667 | Patient 411 treated 4 weeks | 891.77 | 72 |
GSM687670 | Patient 422 treated 24h | 783.061 | 70 |
GSM687671 | Patient 422 treated 4 weeks | 543.458 | 65 |
GSM687654 | Patient 403 treated 24h | 449.114 | 63 |
GSM687675 | Patient 424 treated 24h | 825.571 | 71 |
GSM687685 | Patient 427 treated 24h | 562.683 | 65 |
GSM687656 | Patient 403 treated 4 weeks | 573.087 | 66 |
GSM687677 | Patient 424 treated 4 weeks | 384.068 | 59 |
GSM687687 | Patient 427 treated 4 weeks | 231.933 | 52 |
GSM687692 | Patient 428 treated 4h | 209.556 | 49 |
GSM687716 | Patient 449 treated 4h | 189.487 | 48 |
GSM687722 | Patient 450 treated 4h | 1844.43 | 83 |
GSM687680 | Patient 425 treated 24h | 932.879 | 73 |
GSM687690 | Patient 428 treated 24h | 500.333 | 64 |
GSM687700 | Patient 443 treated 24h | 3788.2 | 92 |
GSM687705 | Patient 444 treated 24h | 801.438 | 71 |
GSM687714 | Patient 449 treated 24h | 365.812 | 60 |
GSM687721 | Patient 450 treated 24h | 2543.26 | 87 |
GSM687682 | Patient 425 treated 4 weeks | 563.459 | 66 |
GSM687694 | Patient 428 treated 4 weeks | 534.899 | 64 |
GSM687702 | Patient 443 treated 4 weeks | 1388.12 | 79 |
GSM687718 | Patient 449 treated 4 weeks | 314.513 | 57 |
GSM687723 | Patient 450 treated 4 weeks | 492.339 | 63 |
GSM687661 | Patient 404 treated 4h | 1842.93 | 83 |
GSM687710 | Patient 448 treated 4h | 1078.08 | 76 |
GSM687726 | Patient 451 treated 4h | 1108.32 | 76 |
GSM687730 | Patient 452 treated 4h | 7268 | 96 |
GSM687660 | Patient 404 treated 24h | 6294.42 | 95 |
GSM687697 | Patient 441 treated 24h | 6002.43 | 95 |
GSM687709 | Patient 448 treated 24h | 790.471 | 71 |
GSM687725 | Patient 451 treated 24h | 1428.59 | 80 |
GSM687729 | Patient 452 treated 24h | 7048.4 | 95 |
GSM687727 | Patient 451 treated 4 weeks | 738.618 | 69 |
GSM687731 | Patient 452 treated 4 weeks | 2017.16 | 84 |